Bonus BioGroup Ltd. (TLV:BONS)
26.70
+0.20 (0.75%)
Dec 8, 2025, 5:24 PM IDT
Bonus BioGroup Market Cap
Bonus BioGroup has a market cap or net worth of 311.84 million as of December 8, 2025. Its market cap has increased by 128.21% in one year.
Market Cap
311.84M
Enterprise Value
320.24M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
26.70
Market Cap Chart
Since July 25, 2012, Bonus BioGroup's market cap has increased from 12.36M to 311.84M, an increase of 2,422.42%. That is a compound annual growth rate of 27.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 7, 2025 | 311.84M | 124.37% |
| Dec 31, 2024 | 138.98M | -28.74% |
| Dec 31, 2023 | 195.04M | -13.02% |
| Dec 29, 2022 | 224.24M | -84.58% |
| Dec 30, 2021 | 1.45B | 200.74% |
| Dec 31, 2020 | 483.51M | 29.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 105.71B |
| Danel (Adir Yeoshua) | 2.71B |
| Kamada | 1.33B |
| BrainsWay | 1.08B |
| Bait Bakfar | 1.04B |
| SofWave Medical | 997.78M |
| Ilex Medical | 717.72M |
| Novolog (Pharm-Up 1966) | 644.72M |